Vincent S Fan1, Jason A Dominitz2, McKenna C Eastment3, Emily Locke4, Pamela Green4, Kristin Berry4, Ann M O'Hare5, Javeed A Shah3, Kristina Crothers1, George N Ioannou2. 1. Division of Pulmonary and Critical Care, University of Washington, Seattle, WA, USA. 2. Division of Gastroenterology, University of Washington, Seattle, WA, USA. 3. Division of Allergy and Infectious Disease, University of Washington, Seattle, WA, USA. 4. Division of Research and Development, University of Washington, Seattle, WA, USA. 5. Division of Nephrology at the Veterans Affairs Puget Sound Healthcare System and University of Washington, Seattle, WA, USA.
Abstract
BACKGROUND: Identifying risk factors for SARS-CoV-2 infection could help health systems improve testing and screening strategies. OBJECTIVES: Identify demographic factors, comorbid conditions, and symptoms independently associated with testing positive for SARS-CoV-2. DESIGN: Observational cross-sectional study. SETTING: Veterans Health Administration. PATIENTS: Persons tested for SARS-CoV-2 nucleic acid by polymerase chain reaction (PCR) between March 1 and May 14, 2020. MEASUREMENTS: Associations between demographic characteristics, diagnosed comorbid conditions, and documented symptoms with testing positive for SARS-CoV-2. RESULTS: Of 88,747 persons tested, 10,131 (11.4%) were SARS-CoV-2 PCR positive. Positivity was associated with older age (≥80 vs. <50 years: aOR 2.16, 95% CI 1.97-2.37), male sex (aOR 1.45, 95% CI 1.34-1.57), regional SARS-CoV-2 burden (≥2,000 vs. <400 cases/million: aOR 5.43, 95% CI 4.97-5.93), urban residence (aOR 1.78, 95% CI 1.70-1.87), Black (aOR 2.15, 95% CI 2.05-2.26) or American Indian/Alaska Native/Pacific Islander (aOR 1.26, 95% CI 1.05-1.52) vs. White race, and Hispanic ethnicity (aOR 1.52, 95% CI 1.40-1.65). Obesity and diabetes were the only two medical conditions associated with testing positive. Documented fevers, chills, cough, and diarrhea were also associated with testing positive. The population attributable fraction of positive tests was highest for regional SARS-CoV-2 burden (35.3%), followed by demographic variables (27.2%), symptoms (12.0%), obesity (10.5%), and diabetes (0.4%). LIMITATIONS: Lack of information on SARS-CoV-2 exposures or the indications for testing which may affect the likelihood of testing positive. CONCLUSION: The majority of positive SARS-CoV-2 tests were attributed to regional SARS-CoV-2 burden, demographic characteristics and obesity with a minor contribution of chronic comorbid conditions. Published by Oxford University Press for the Infectious Diseases Society of America 2020. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: Identifying risk factors for SARS-CoV-2 infection could help health systems improve testing and screening strategies. OBJECTIVES: Identify demographic factors, comorbid conditions, and symptoms independently associated with testing positive for SARS-CoV-2. DESIGN: Observational cross-sectional study. SETTING: Veterans Health Administration. PATIENTS: Persons tested for SARS-CoV-2 nucleic acid by polymerase chain reaction (PCR) between March 1 and May 14, 2020. MEASUREMENTS: Associations between demographic characteristics, diagnosed comorbid conditions, and documented symptoms with testing positive for SARS-CoV-2. RESULTS: Of 88,747 persons tested, 10,131 (11.4%) were SARS-CoV-2 PCR positive. Positivity was associated with older age (≥80 vs. <50 years: aOR 2.16, 95% CI 1.97-2.37), male sex (aOR 1.45, 95% CI 1.34-1.57), regional SARS-CoV-2 burden (≥2,000 vs. <400 cases/million: aOR 5.43, 95% CI 4.97-5.93), urban residence (aOR 1.78, 95% CI 1.70-1.87), Black (aOR 2.15, 95% CI 2.05-2.26) or American Indian/Alaska Native/Pacific Islander (aOR 1.26, 95% CI 1.05-1.52) vs. White race, and Hispanic ethnicity (aOR 1.52, 95% CI 1.40-1.65). Obesity and diabetes were the only two medical conditions associated with testing positive. Documented fevers, chills, cough, and diarrhea were also associated with testing positive. The population attributable fraction of positive tests was highest for regional SARS-CoV-2 burden (35.3%), followed by demographic variables (27.2%), symptoms (12.0%), obesity (10.5%), and diabetes (0.4%). LIMITATIONS: Lack of information on SARS-CoV-2 exposures or the indications for testing which may affect the likelihood of testing positive. CONCLUSION: The majority of positive SARS-CoV-2 tests were attributed to regional SARS-CoV-2 burden, demographic characteristics and obesity with a minor contribution of chronic comorbid conditions. Published by Oxford University Press for the Infectious Diseases Society of America 2020. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: George N Ioannou; Amy S B Bohnert; Ann M O'Hare; Edward J Boyko; Matthew L Maciejewski; Valerie A Smith; C Barrett Bowling; Elizabeth Viglianti; Theodore J Iwashyna; Denise M Hynes; Kristin Berry Journal: Ann Intern Med Date: 2022-10-11 Impact factor: 51.598
Authors: George N Ioannou; Jacqueline M Ferguson; Ann M O'Hare; Amy S B Bohnert; Lisa I Backus; Edward J Boyko; Thomas F Osborne; Matthew L Maciejewski; C Barrett Bowling; Denise M Hynes; Theodore J Iwashyna; Melody Saysana; Pamela Green; Kristin Berry Journal: PLoS Med Date: 2021-10-21 Impact factor: 11.613
Authors: Mohammad Talaei; Sian Faustini; Hayley Holt; David A Jolliffe; Giulia Vivaldi; Matthew Greenig; Natalia Perdek; Sheena Maltby; Carola M Bigogno; Jane Symons; Gwyneth A Davies; Ronan A Lyons; Christopher J Griffiths; Frank Kee; Aziz Sheikh; Alex G Richter; Seif O Shaheen; Adrian R Martineau Journal: BMC Med Date: 2022-02-22 Impact factor: 8.775
Authors: Thomas Marjot; Gwilym J Webb; Alfred S Barritt; Andrew M Moon; Zania Stamataki; Vincent W Wong; Eleanor Barnes Journal: Nat Rev Gastroenterol Hepatol Date: 2021-03-10 Impact factor: 73.082
Authors: Hoda S Abdel Magid; Jacqueline M Ferguson; Raymond Van Cleve; Amanda L Purnell; Thomas F Osborne Journal: Int J Environ Res Public Health Date: 2021-12-13 Impact factor: 3.390
Authors: George N Ioannou; Peter S Liang; Emily Locke; Pamela Green; Kristin Berry; Ann M O'Hare; Javeed A Shah; Kristina Crothers; McKenna C Eastment; Vincent S Fan; Jason A Dominitz Journal: Hepatology Date: 2021-06-02 Impact factor: 17.298